Order Entry
United States
ContactUsLinkComponent
OsteoSense 800 Fluorescent Imaging Agent, PerkinElmer
OsteoSense 800 Fluorescent Imaging Agent, PerkinElmer
Catalog # 101687-116
Supplier:  Avantor
CAS Number:  
undefined
OsteoSense 800 Fluorescent Imaging Agent, PerkinElmer
Catalog # 101687-116
Supplier:  Avantor
CAS Number:  
Restricted Products: To process your orders without delay, please provide the required business documentation to purchase this product.

To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:

  • • State issued document with your organization's Federal Tax ID Number
  • • State issued document with your organization's Resale Tax ID Number
  • • City or County issued Business License
  • • State Department of Health Services License
  • • Any other ID issued by the State that includes the business name & address

* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.

Specifications

  • Description:
    OsteoSense 800
  • Environmentally Preferable:
  • Shipping Conditions:
    Shipped Ambient
  • Storage Temperature:
    2 to 8 °C
  • Cat. No.:
    101687-116
  • Supplier no.:
    NEV11105

Specifications

About this item

OsteoSense® 800 is a targeted fluorescent in vivo bisphosphonate imaging agent

OsteoSense 800 images areas of microcalcifications and bone remodeling and enables imaging of bone growth and resorption. OsteoSense 800 fluorescent imaging agent at a wavelenth at 800 nm, can be used to measure the effects of therapeutic stimulation of bone growth. This agent can also be used to characterize bone remodeling associated with animal models of arthritis. OsteoSense 800 enables in vivo detection, measurement and monitoring of skeletal changes in a wide range of disease states, including arthritis, osteoporosis, and cancer metastasis.